BPIQ Portfolio & Back-Testing Update

As we have discussed in prior posts, we transitioned our BPIQ model portfolios to strategies that utilized top holdings of bio/pharma-focused funds. This post updates the performance of those model portfolios in their first full year. Furthermore, this post presents results of more back-testing we performed as we tested similar and further refined sub-strategies based on hedge-fund favorite holdings. Four conclusions can be drawn from this work:

Want to read more?

Subscribe to bpiq.com to keep reading this exclusive post.

Subscribe Now